Expert opinion on vaccination of travelers against Japanese encephalitis

Journal of Travel Medicine

Volumn 16, Issue 3, 2009, Pages 204-216

  Burchard, Gerd D ^a   Caumes, Eric ^b   Connor, Bradley A ^c   Freedman, David O ^d   Jelinek, Tomas ^e   Jong, Elaine C ^f   Von Sonnenburg, Frank ^g   Steffen, Robert ^h   Tsai, Theodore F ⁱ   Wilder Smith, Annelies ^j   Zuckerman, Jane ^k  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d University of Alabama at Birmingham   (United States)

^e Berlin Center for Travel and Tropical Medicine   (Germany)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ Novartis Vaccines Cambridge   (United States)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; IXIARO; JAPANESE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ASIA; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG INDICATION; ENCEPHALOMYELITIS; EPIDEMIC ENCEPHALITIS; FACE EDEMA; GEOGRAPHIC DISTRIBUTION; HEPATITIS A; HUMAN; INFECTION PREVENTION; INFECTION RISK; JAPANESE ENCEPHALITIS VIRUS; LUNG EDEMA; NONHUMAN; PRACTICE GUIDELINE; REVIEW; TRAVEL; TREATMENT INDICATION; VACCINATION;

ASIA; DISEASE OUTBREAKS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GEOGRAPHY; HUMANS; JAPANESE ENCEPHALITIS VACCINES; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TRAVEL;

EID: 65749111284     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2009.00330.x     Document Type: Review

References (133)

1. Centers for Disease Control and Prevention. Inactivated Japanese encephalitis virus vaccine: recommendation of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 1993 42 : (RR-1).
2. Buhl MR, Lindquist L. Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk. J Travel Med 2009 16 : 217 219.
3. Lehtinen VA, Huhtamo E, Siikamaki H, Vapalahti O. Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand. J Clin Virol 2008 43 : 93 95.
4. Huber D. 9-year-old faces hard recovery after catching rare virus in Asia. Seattle, WA: The Olympian, 2008.
5. Caramello P, Canta F, Balbiano R, et al. A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader? J Travel Med 2007 14 : 346 348. (Pubitemid 47460248)
6. Wittesjo B, Eitrem R, Niklasson B, et al. Japanese encephalitis after a 10-day holiday in Bali. Lancet 1995 345 : 856 857.
7. Macdonald WB, Tink AR, Ouvrier RA, et al. Japanese encephalitis after a two-week holiday in Bali. Med J Aust 1989 150 : 334 336, 339. (Pubitemid 19091964)
8. Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002 35 : 183 188. (Pubitemid 34753904)
9. Japan Ministry of Health Law. About the forbearance of positive encouragement of the encephalitis B vaccination. 2005. Available at : http://www.mhlw.go.jp/topics/2005/05/tp0530-1 Accessed 2008 Dec 1)
10. Tauber E, Kollaritsch H, von Sonnenburg F, et al. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of ic51, an inactivated Japanese encephalitis vaccine. J Infect Dis 2008 198 : 493 499.
11. Tauber E, Kollaritsch H, Korinek M, et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007 370 : 1847 1853. (Pubitemid 350186053)
12. Schuller E, Jilma B, Voicu V, et al. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. Vaccine 2008 26 : 4382 4386.
13. Konishi E, Suzuki T. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations. Vaccine 2002 21 : 98 107. (Pubitemid 35351355)
14. Tsai T, Yu Y. Japanese encephalitis vaccines. In : Plotkin S, Orenstein W, eds. Vaccines. 3rd Ed. Philadelphia, PA : WB Saunders, 1999 : 672 710.
15. Ding D, Hong Z, Zhao SJ, et al. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg 2007 77 : 528 533.
16. Liu W, Clemens JD, Kari K, Xu ZY. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia. Vaccine 2008 26 : 4456 4460.
17. Ooi MH, Lewthwaite P, Lai BF, et al. The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central Sarawak, Malaysia, 1997-2005. Clin Infect Dis 2008 47 : 458 468.
18. Pieper SJ, Jr., Kurland LT. Sequelae of Japanese B and mumps encephalitis: recent follow-up of patients affected in 1947-1948 epidemic on Guam. Am J Trop Med Hyg 1958 7 : 481 490.
19. Paul WS, Moore PS, Karabatsos N, et al. Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis 1993 167 : 1053 1058.
20. Hanna JN, Ritchie SA, Phillips DA, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996 165 : 256 260.
21. Hammon WM, Tigertt WD, Sather GE, et al. Epidemiologic studies of concurrent virgin epidemics of Japanese B encephalitis and of mumps on Guam, 1947-1948, with subsequent observations including dengue, through 1957. Am J Trop Med Hyg 1958 7 : 441 467.
22. Endy TP, Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 2002 267 : 11 48. (Pubitemid 34411357)
23. Igarashi A. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr Top Microbiol Immunol 2002 267 : 139 152. (Pubitemid 34411362)
24. Rosen L. The natural history of Japanese encephalitis virus. Annu Rev Microbiol 1986 40 : 395 414.
25. Burke DS, Leake CJ. Japanese encephalitis. In : Monath TP, ed. The arboviruses: epidemiology and ecology. Boca Raton, FL : CRC Press, 1988 : 63 92.
26. Oya A. Japanese encephalitis vaccine. Acta Paediatr Jpn 1988 30 : 175 184. (Pubitemid 18147797)
27. Wu YC, Huang YS, Chien LJ, et al. The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am J Trop Med Hyg 1999 61 : 78 84. (Pubitemid 29344993)
28. Sohn YM. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis 2000 6 : 17 24. (Pubitemid 30126447)
29. Li YX, Yin ZD, Yang JF, et al. [Epidemic situation analysis of Japanese encephalitis in 2005.]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2006 20 : 216 218.
30. Zhou B, Jia L, Xu X. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas]. Zhonghua Liu Xing Bing Xue Za Zhi 1999 20 : 38 41.
31. Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 2000 18 (Suppl 2 1 25.
32. World Tourism Organization (UNWTO). Tourism 2020 vision. 2007. Available at : http://unwtoorg/facts/eng/visionhtm Accessed 2008 Dec 1)
33. World Tourism Organization (UNWTO). UNWTO World Tourism Barometer. 2008 6 3 1 51. www.unwto.org.
34. World Tourism Organization (UNWTO). Tourism Market Trends 2005: Asia and Pacific. Madrid, Spain : World Tourism Organization. 2006.
35. Davis X, Marano N, von Sonnenburg F, et al. Disease outcomes among travelers with different travel purposes: findings from GeoSentinel. 2nd Northern European Conference on Travel Medicine, Helsinki, Finland, 2008 Abstr F6 F4)
36. Kari K, Liu W, Gautama K, et al. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 2006 4 : 8. (Pubitemid 43949673)
37. Berg SW, Mitchell BS, Hanson RK, et al. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. Clin Infect Dis 1997 24 : 265 266. (Pubitemid 27081554)
38. Hoke CH, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988 319 : 608 614. (Pubitemid 18209710)
39. Benenson MW, Top FH, Jr., Gresso W, et al. The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg 1975 24 : 974 980.
40. Grossman RA, Edelman R, Chiewanich P, et al. Study of Japanese encephalitis virus in Chiangmai valley, Thailand. II. Human clinical infections. Am J Epidemiol 1973 98 : 121 132.
41. Hsu TC, Chow LP, Wei HY, et al. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine. Taiwan Yi Xue Hui Za Zhi 1971 70 : 55 62.
42. Okuno T, Tseng PT, Hsu ST, et al. Japanese encephalitis surveillance in China (Province of Taiwan) during 1968-1971. II. Age-specific incidence in connection with Japanese encephalitis vaccination program. Jpn J Med Sci Biol 1975 28 : 255 267.
43. Rojanasuphot S, Tsai TF. Regional workshop on control strategies for Japanese encephalitis. Southeast Asian J Trop Med Public Health 1995 26 : 1 59.
44. Wong SC, Ooi MH, Abdullah AR, et al. A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997-2006. Trop Med Int Health 2008 13 : 52 55.
45. Solomon T, Thao TT, Lewthwaite P, et al. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ 2008 86 : 178 186.
46. Yu Y. Japanese encephalitis in China. Southeast Asian J Trop Med Public Health 1995 26 : 17 22.
47. Kanojia PC, Shetty PS, Geevarghese G. A long-term study on vector abundance & seasonal prevalence in relation to the occurrence of Japanese encephalitis in Gorakhpur district, Uttar Pradesh. Indian J Med Res 2003 117 : 104 110. (Pubitemid 37203474)
48. Pogodina VV, Bochkova NG, Leshchinskaia EV, Levina LS. [Japanese encephalitis in citizens of Russia who travel abroad]. Vopr Virusol 1996 41 : 8 11.
49. Watt G, Jongsakul K. Acute undifferentiated fever caused by infection with Japanese encephalitis virus. Am J Trop Med Hyg 2003 68 : 704 706. (Pubitemid 38235100)
50. Cardosa MJ, Hooi TP, Kaur P. Japanese encephalitis virus is an important cause of encephalitis among children in Penang. Southeast Asian J Trop Med Public Health 1995 26 : 272 275.
51. Chung CC, Lee SS, Chen YS, et al. Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and review of the literature. Infection 2007 35 : 30 32. (Pubitemid 46295043)
52. Hosokawa T, Nakajima H, Takasaki T, et al. [Case report of aseptic meningitis due to Japanese encephalitis virus]. Rinsho Shinkeigaku 2007 47 : 109 111. (Pubitemid 46770440)
53. Kabilan L, Ramesh S, Srinivasan S, et al. Hospital- and laboratory-based investigations of hospitalized children with central nervous system-related symptoms to assess Japanese encephalitis virus etiology in Cuddalore District, Tamil Nadu, India. J Clin Microbiol 2004 42 : 2813 2815. (Pubitemid 38747548)
54. Chhour YM, Ruble G, Hong R, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis 2002 8 : 485 489. (Pubitemid 34533325)
55. Natividad FF, Daroy ML, Alonzo MT, et al. Use of IgM-capture ELISA for confirmation of Japanese encephalitis infections in the Philippines. Southeast Asian J Trop Med Public Health 2006 37 (Suppl 3 136 139.
56. Arai S, Matsunaga Y, Takasaki T, et al. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004. Jpn J Infect Dis 2008 61 : 333 338.
57. Infectious Disease Surveillance Center. Department of Health J. Japanese encephalitis HI antibody prevalence of swine in Japan. 2007. http://idsc.nih.go.jp/yosuku/JE/JEmap2007-E.html Accessed 2008 Dec 1)
58. Konishi E, Shoda M, Kondo T. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Vaccine 2006 24 : 516 524. (Pubitemid 41832556)
59. Nidaira M, Taira K, Itokazu K, et al. Survey of the antibody against Japanese encephalitis virus in Ryukyu wild boars (Sus scrofa riukiuanus) in Okinawa, Japan. Jpn J Infect Dis 2007 60 : 309 311. (Pubitemid 47516881)
60. See E, Tan HC, Wang D, et al. Presence of hemagglutination inhibition and neutralization antibodies to Japanese encephalitis virus in wild pigs on an offshore island in Singapore. Acta Trop 2002 81 : 233 236. (Pubitemid 34143238)
61. Hamano M, Lim CK, Takagi H, et al. Detection of antibodies to Japanese encephalitis virus in the wild boars in Hiroshima prefecture, Japan. Epidemiol Infect 2007 135 : 974 977. (Pubitemid 47616478)
62. Yang DK, Kweon CH, Kim BH, et al. The seroprevalence of Japanese encephalitis virus in goats raised in Korea. J Vet Sci 2007 8 : 197 199. (Pubitemid 46842650)
63. Turell MJ, Mores CN, Dohm DJ, et al. Laboratory transmission of Japanese encephalitis, West Nile, and Getah viruses by mosquitoes (Diptera: Culicidae) collected near Camp Greaves, Gyeonggi Province, Republic of Korea 2003. J Med Entomol 2006 43 : 1076 1081.
64. Matsunaga T, Shoda M, Konishi E. Japanese encephalitis viral infection remains common in Japan. Pediatr Infect Dis J 2008 27 : 769 770.
65. Konishi E, Shoda M, Yamamoto S, et al. Natural infection with Japanese encephalitis virus among inhabitants of Japan: a nationwide survey of antibodies against nonstructural 1 protein. Vaccine 2006 24 : 3054 3056.
66. Gingrich JB, Nisalak A, Latendresse JR, et al. A longitudinal study of Japanese encephalitis in suburban Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1987 18 : 558 566.
67. Gingrich JB, Nisalak A, Latendresse JR, et al. Japanese encephalitis virus in Bangkok: factors influencing vector infections in three suburban communities. J Med Entomol 1992 29 : 436 444.
68. Oya A, Kurane I. Japanese encephalitis for a reference to international travelers. J Travel Med 2007 14 : 259 268. (Pubitemid 47041480)
69. Ritchie SA, Rochester W. Wind-blown mosquitoes and introduction of Japanese encephalitis into Australia. Emerg Infect Dis 2001 7 : 900 903. (Pubitemid 33121603)
70. Nga PT, del Carmen PM, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 2004 85 : 1625 1631. (Pubitemid 38807760)
71. Ming JG, Jin H, Riley JR, et al. Autumn southward 'return' migration of the mosquito Culex tritaeniorhynchus in China. Med Vet Entomol 1993 7 : 323 327. (Pubitemid 24418023)
72. Nidaira M, Taira K, Onodera I, et al. Detection of Japanese encephalitis virus antibody in a pig on Yonaguni Island, where all pigs were slaughtered in 1997. Jpn J Infect Dis 2007 60 : 70 71. (Pubitemid 46443727)
73. Kanojia PC, Geevarghese G. First report on high-degree endophilism in Culex tritaeniorhynchus (Diptera: Culicidae) in an area endemic for Japanese encephalitis. J Med Entomol 2004 41 : 994 996. (Pubitemid 39403949)
74. Tsai TF. Flaviviruses. In : Mandell G, Bennett J, Dolin R, eds. Principles and practice of infectious diseases. 5th Ed. Philadelphia, PA : Churchill-Livingston, 2000 : 1714 1736.
75. Ayukawa R, Fujimoto H, Ayabe M, et al. An unexpected outbreak of Japanese encephalitis in the Chugoku district of Japan, 2002. Jpn J Infect Dis 2004 57 : 63 66. (Pubitemid 38679055)
76. Xu ZQ, Fu SH, Zhang YP, et al. [Laboratory testing of sepcimens from patients with viral encephalitis from some regions of China]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008 22 : 98 100.
77. Zhang DL, Ma LB, Fu SH, et al. Clinical characteristics and laboratory assay of adult Japanese encephalitis patients in an outbreak in Yuncheng, Shanxi Province, 2006]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008 22 : 95 97.
78. Monath TP, Tsai TF. Flaviviruses. In : Richman D, Whitley R, Hayden F, eds. Clinical virology. 2nd Ed. Washington, DC : American Society of Microbiology, 2002 : 1097 1092.
79. Tsai TF, Canfield MA, Reed CM, et al. Epidemiological aspects of a St. Louis encephalitis outbreak in Harris County, Texas, 1986. J Infect Dis 1988 157 : 351 356. (Pubitemid 18061250)
80. Das S, Basu A. Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J Neurochem 2008 106 : 1624 1636.
81. Khairallah M, Yahia SB, Letaief M, et al. A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection. Ocul Immunol Inflamm 2007 15 : 435 439. (Pubitemid 350293547)
82. Brown JA, Factor DL, Tkachenko N, et al. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis 2007 7 : 479 488.
83. Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 2006 134 : 1325 1332. (Pubitemid 44614956)
84. Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 2007 13 : 1918 1920.
85. Broun GO. Relationship of hypertensive vascular disease to mortality in cases of St. Louis encephalitis. Med Bull St Louis Univ 1952 4 : 32 37.
86. Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004 77 : 399 402. (Pubitemid 38209739)
87. McElhaney JE, Herre JM, Lawson ML, et al. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 2004 22 : 681 688. (Pubitemid 38114898)
88. Bond JO, Hammon WM. Epidemiologic studies of possible cross protection between dengue and St. Louis encephalitis arboviruses in Florida. Am J Epidemiol 1970 92 : 321 329.
89. Edelman R, Schneider RJ, Chieowanich P, et al. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health 1975 6 : 308 315.
90. Libraty DH, Nisalak A, Endy TP, et al. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 2002 96 : 173 178.
91. Chan-Tack KM, Forrest G. West Nile virus meningoencephalitis and acute flaccid paralysis after infliximab treatment. J Rheumatol 2006 33 : 191 192. (Pubitemid 43054302)
92. Liu YF, Teng CL, Liu K. Cerebral cysticercosis as a factor aggravating Japanese B encephalitis. Chin Med J 1957 75 : 1010 1017.
93. Handique SK, Das RR, Saharia B, et al. Coinfection of Japanese encephalitis with neurocysticercosis: an imaging study. AJNR Am J Neuroradiol 2008 29 : 170 175.
94. Singh P, Kalra N, Ratho RK, et al. Coexistent neurocysticercosis and Japanese B encephalitis: MR imaging correlation. AJNR Am J Neuroradiol 2001 22 : 1131 1136. (Pubitemid 32587427)
95. Das SK, Nityanand S, Sood K, et al. Japanese B encephalitis with neurocysticercosis. J Assoc Physicians India 1991 39 : 643 644.
96. Desai A, Shankar SK, Jayakumar PN, et al. Co-existence of cerebral cysticercosis with Japanese encephalitis: a prognostic modulator. Epidemiol Infect 1997 118 : 165 171. (Pubitemid 27170808)
97. Azad R, Gupta RK, Kumar S, et al. Is neurocysticercosis a risk factor in coexistent intracranial disease? An MRI based study. J Neurol Neurosurg Psychiatry 2003 74 : 359 361. (Pubitemid 36259365)
98. Hayashi K, Arita T. Experimental double infection of Japanese encephalitis virus and herpes simplex virus in mouse brain. Jpn J Exp Med 1977 47 : 9 13. (Pubitemid 8066793)
99. Lange DG, Sedmak J. Japanese encephalitis virus (JEV): potentiation of lethality in mice by microwave radiation. Bioelectromagnetics 1991 12 : 335 348.
100. Gutierrez K, Abzug MJ. Vaccine-associated poliovirus meningitis in children with ventriculoperitoneal shunts. J Pediatr 1990 117 : 424 427. (Pubitemid 20315666)
101. Wei BP, Robins-Browne RM, Shepherd RK, et al. Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis 2008 46 : e1 e7.
102. Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003 52 : 739 740.
103. Mathur A, Tandon HO, Mathur KR, et al. Japanese encephalitis virus infection during pregnancy. Indian J Med Res 1985 81 : 9 12.
104. Chaturvedi UC, Mathur A, Chandra A, et al. Transplacental infection with Japanese encephalitis virus. J Infect Dis 1980 141 : 712 715. (Pubitemid 10070024)
105. Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 2003 136 : 733 735. (Pubitemid 37153191)
106. Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep 2004 53 : 154 157.
107. O'Leary DR, Kuhn S, Kniss KL, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006 117 : e537 e545. (Pubitemid 46063194)
108. Paisley JE, Hinckley AF, O'Leary DR, et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics 2006 117 : 814 820. (Pubitemid 46063224)
109. Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep 2002 51 : 1135 1136.
110. Tsai TF. Congenital arboviral infections: something new, something old. Pediatrics 2006 117 : 936 939. (Pubitemid 46063239)
111. Lim JK, Louie CY, Glaser C, et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 2008 197 : 262 265.
112. Lim JK, Glass WG, McDermott DH, Murphy PM. CCR5: no longer a "good for nothing" gene - chemokine control of West Nile virus infection. Trends Immunol 2006 27 : 308 312. (Pubitemid 43963479)
113. Diamond MS, Klein RS. A genetic basis for human susceptibility to West Nile virus. Trends Microbiol 2006 14 : 287 289. (Pubitemid 43963363)
114. Ferenczi E, Ban E, Abraham A, et al. Severe tick-borne encephalitis in a patient previously infected by West Nile virus. Scand J Infect Dis 2008 40 : 759 761.
115. Kindberg E, Mickiene A, Ax C, et al. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 2008 197 : 266 269.
116. Offit PA, Peter G. The meningococcal vaccine - public policy and individual choices. N Engl J Med 2003 349 : 2353 2356. (Pubitemid 37509744)
117. Plesner AM. Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin North Am 2003 23 : 665 697. (Pubitemid 38035120)
118. Andersen MM, Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet 1991 337 : 1044.
119. Plesner A, Ronne T, Wachmann H. Case-control study of allergic reactions to Japanese encephalitis vaccine. Vaccine 2000 18 : 1830 1836. (Pubitemid 30122845)
120. Plesner AM, Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 1997 15 : 1239 1243. (Pubitemid 27372107)
121. Sakaguchi M, Nakashima K, Takahashi H, et al. Anaphylaxis to Japanese encephalitis vaccine. Allergy 2001 56 : 804 805. (Pubitemid 32681727)
122. Sakaguchi M, Miyazawa H, Inouye S. Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines. Allergy 2001 56 : 536 539. (Pubitemid 32521435)
123. Sakaguchi M, Inouye S. Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines. Vaccine 1998 16 : 68 69. (Pubitemid 27504806)
124. Sakaguchi M, Yoshida M, Kuroda W, et al. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine 1997 15 : 121 122. (Pubitemid 27091239)
125. Plesner AM, Arlien-Soborg P, Herning M. Neurological complications to vaccination against Japanese encephalitis. Eur J Neurol 1998 5 : 479 485. (Pubitemid 28470002)
126. Takahashi H, Pool V, Tsai1 TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000 18 : 2963 2969.
127. Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine 2007 25 : 570 576.
128. Centers for Disease Control and Prevention. Announcement for healthcare professionals: Japanese Encephalitis Vaccine Availability. 2008. Available at : http://wwwn.cdc.gov/travel/contentJapaneseEncephVaccine.aspx Accessed 2008 Dec 1)
129. Japanese encephalitis in a U.S. traveler returning from Thailand, 2004. MMWR Morb Mortal Wkly Rep 2005 54 : 123 125.
130. Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit. Recommendations on travel vaccines. 2008. Available at : http://www.dtg.org/impfungen.html Accessed 2008 Dec 1)
131. Institut de Veille Sanitaire. Health recommendations for travelers. 2007. Available at : http://www.invs.sante.fr/beh/default.htm Accessed 2008 Dec 1)
132. National Travel Health Network and Centre. Travel health information sheets - Japanese encephalitis. 2007. Available at : http://www.nathnac.org/pro/ factsheets/index.htm Accessed 2008 Dec 1)
133. Lehner C, Eder G, Formica A, et al. Safety and immunogenicity of concomitant vaccination with IC51 and Hepatitis A vaccine in healthy subjects. A single-blind randomized controlled phase 3 study. Abstracts of the 56th American Society of Tropical Medicine and Hygiene Annual Meeting 2007. (Abstr 122)